Top Markets
Coin of the day
Enzo Biochem, Inc. Enzo Biochem, Inc.

Enzo Biochem, Inc.

ENZ
Classificação em ações #28166
Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics,... Enzo Biochem, Inc. is a diversified enterprise that encompasses diagnostics, clinical laboratory services, and life sciences. The company's core activities involve the entire process of researching, developing, manufacturing, and commercializing diagnostic and scientific investigation products, drawing upon advancements in genetic engineering, biotechnology, and molecular biology. Its operations are organized into three primary segments: Life Sciences Products, Clinical Laboratory Services, and Therapeutics. The Life Sciences Products division is responsible for creating, producing, and distributing vital tools and reagents tailored for customers in clinical research, pharmaceutical development, and broader bioscience research. Its extensive product catalog features items such as proteins, antibodies, peptides, small molecules, labeling agents, dyes, and various kits. These offerings provide life science researchers with the means for target identification and validation, content analysis, gene expression studies, nucleic acid detection, protein biochemistry and detection, and cellular analysis. This segment also supplies specialized solutions to scientific experts investigating critical health areas, including cancer, cardiovascular ailments, neurological disorders, metabolic conditions (like diabetes and obesity), endocrine imbalances, infectious and autoimmune diseases, hepatotoxicity, and renal injury. The Clinical Laboratory Services segment delivers a comprehensive spectrum of molecular and other clinical laboratory tests and procedures. These are utilized by physicians in routine patient care to help confirm or establish diagnoses, monitor the effectiveness of treatments or medications, and identify previously undiagnosed medical conditions. This division operates a central, full-service clinical laboratory in Farmingdale, New York, complemented by a network of 30 patient service centers across New York and New Jersey. Additionally, it runs dedicated "STAT" or rapid-response laboratories in New York City and Connecticut, alongside a full-service phlebotomy facility and an internal logistics department. The Therapeutics segment is dedicated to pioneering novel treatment approaches within the fields of gastrointestinal, infectious, ophthalmic, and metabolic diseases. Enzo Biochem distributes its array of products and services through its dedicated internal sales team and an extensive network of distributors, reaching both domestic and international markets. The company was established in 1976 and has its corporate headquarters situated in New York, New York.
Preço da ação
$0.5495
Última sincronização: 2025-05-15
Valor de mercado
$28.14M
Variação (1 dia)
4.70%
Variação (1 ano)
0.00%
País
US
Negociar Enzo Biochem, Inc. (ENZ)

Categoria

Rácio P/E de Enzo Biochem, Inc. (ENZ)
Rácio P/E em August 2026 TTM: -0.62
De acordo com os últimos relatórios financeiros e o preço das ações da Enzo Biochem, Inc., o rácio P/E atual (TTM) é -0.62. No final de 2023, a empresa tinha um P/E de 3.59.
Histórico do rácio P/E da Enzo Biochem, Inc. de 2000 a 2026
Rácio P/E no final de cada ano
Ano Índice P/E Alterar
2026 (TTM) -0.62 -72.41%
2024 -2.23 -162.05%
2023 3.59 -168.85%
2022 -5.21 -111.36%
2021 45.87 -1,469.40%
2020 -3.35 78.71%
2019 -1.87 -90.67%
2018 -20.09 -90.00%
2017 -200.84 -3,032.49%
2016 6.85 -111.50%
2015 -59.55 190.81%
2014 -20.48 332.49%
2013 -4.73 219.47%
2012 -1.48 -86.89%
2011 -11.31 43.80%
2010 -7.86 -3.16%
2009 -8.12 -83.50%
2008 -49.20 45.77%
2007 -33.75 27.33%
2006 -26.50 -114.85%
2005 178.44 -370.03%
2004 -66.08 -139.03%
2003 169.30 211.46%
2002 54.36 -45.50%
2001 99.74 -51.07%
2000 203.85 0.00%
Rácio P/E para empresas semelhantes ou concorrentes
Empresa Rácio P/E Diferença do rácio P/E País
31.59 -5,234.81%
US
35.83 -5,923.48%
US
- -
CN
-227.89 36,937.17%
US
38.69 -6,388.15%
US
Como interpretar um P/E Ratio?

O rácio Preço/Lucro (P/E) mede a relação entre o preço da ação de uma empresa e o lucro por ação.
Um P/E baixo mas positivo representa uma empresa com altos lucros face à sua valorização atual e pode estar subvalorizada. Um P/E negativo elevado (perto de 0) representa perdas significativas.

Empresas com P/E acima de 30 ou negativo são geralmente vistas como "ações de crescimento", significando que os investidores esperam crescimento ou rentabilidade futura.

Empresas com P/E positivo inferior a 10 são geralmente consideradas "ações de valor", ou seja, já são muito lucrativas mas com pouco potencial de crescimento.